NCT01332318View on ClinicalTrials.gov

Simulated Driving Study in Restless Legs Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions
Restless Legs Syndrome
Interventions
DRUG

XP13512

XP13512 once daily for 16 days

DRUG

Diphenhydramine

one 50 mg dose of diphenhydramine (DPH) on day 16

DRUG

Placebo

XP13512 placebo once daily for 16 days

Trial Locations (1)

87108

GSK Investigational Site, Albuquerque

All Listed Sponsors
lead

XenoPort, Inc.

INDUSTRY

NCT01332318 - Simulated Driving Study in Restless Legs Syndrome | Biotech Hunter | Biotech Hunter